Cooperberg MR - Search Results

1

Patient-specific Meta-analysis of 2 Clinical Validation Studies to Predict Pathologic Outcomes in Prostate Cancer Using the 17-Gene Genomic Prostate Score.

Brand TC, Zhang N, Crager MR, Maddala T, Dee A, Sesterhenn IA, Simko JP, Cooperberg MR, Srivastava S, Rosner IL, Chan JM, Febbo PG, Carroll PR, Cullen J, Lawrence HJ. Brand TC, et al. Among authors: cooperberg mr. Urology. 2016 Mar;89:69-75. doi: 10.1016/j.urology.2015.12.008. Epub 2015 Dec 23. Urology. 2016. PMID: 26723180 Free article.

2

Contemporary trends in imaging test utilization for prostate cancer staging: data from the cancer of the prostate strategic urologic research endeavor.

Cooperberg MR, Lubeck DP, Grossfeld GD, Mehta SS, Carroll PR. Cooperberg MR, et al. J Urol. 2002 Aug;168(2):491-5. J Urol. 2002. PMID: 12131295

3

How potent is potent? Evaluation of sexual function and bother in men who report potency after treatment for prostate cancer: data from CaPSURE.

Cooperberg MR, Koppie TM, Lubeck DP, Ye J, Grossfeld GD, Mehta SS, Carroll PR; CaPSURE. Cooperberg MR, et al. Urology. 2003 Jan;61(1):190-6. doi: 10.1016/s0090-4295(02)02118-0. Urology. 2003. PMID: 12559294 Free article.

4

National practice patterns and time trends in androgen ablation for localized prostate cancer.

Cooperberg MR, Grossfeld GD, Lubeck DP, Carroll PR. Cooperberg MR, et al. J Natl Cancer Inst. 2003 Jul 2;95(13):981-9. doi: 10.1093/jnci/95.13.981. J Natl Cancer Inst. 2003. PMID: 12837834 Free PMC article.

5

Cooperberg MR, Master VA, Carroll PR. Cooperberg MR, et al. J Urol. 2003 Aug;170(2 Pt 1):512-5. doi: 10.1097/01.ju.0000074941.27370.c4. J Urol. 2003. PMID: 12853811

6

Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURE.

Harlan SR, Cooperberg MR, Elkin E, Lubeck DP, Meng M, Mehta SS, Carroll PR. Harlan SR, et al. Among authors: cooperberg mr. J Urol. 2003 Nov;170(5):1804-7. doi: 10.1097/01.ju.0000091641.34674.11. J Urol. 2003. PMID: 14532780

7

Time trends in clinical risk stratification for prostate cancer: implications for outcomes (data from CaPSURE).

Cooperberg MR, Lubeck DP, Mehta SS, Carroll PR; CaPSURE. Cooperberg MR, et al. J Urol. 2003 Dec;170(6 Pt 2):S21-5; discussion S26-7. doi: 10.1097/01.ju.0000095025.03331.c6. J Urol. 2003. PMID: 14610406

8

The evolving role of androgen deprivation therapy in the management of prostate cancer.

Cooperberg MR, Small EJ, D'Amico A, Carroll PR. Cooperberg MR, et al. Minerva Urol Nefrol. 2003 Dec;55(4):219-38. Minerva Urol Nefrol. 2003. PMID: 14765015 Review.

9

The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry.

Cooperberg MR, Broering JM, Litwin MS, Lubeck DP, Mehta SS, Henning JM, Carroll PR; CaPSURE Investigators. Cooperberg MR, et al. J Urol. 2004 Apr;171(4):1393-401. doi: 10.1097/01.ju.0000107247.81471.06. J Urol. 2004. PMID: 15017184 Review.

10

Radical retropubic prostatectomy frustrated by prior laparoscopic mesh herniorrhaphy.

Cooperberg MR, Downs TM, Carroll PR. Cooperberg MR, et al. Surgery. 2004 Apr;135(4):452-3; discussion 454. doi: 10.1016/j.surg.2003.10.014. Surgery. 2004. PMID: 15041971 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

544 results

Search Page

Filters